Lorraine Meisner, Ph.D.
Chief Scientific Officer
Dr. Lorraine Meisner is Emerita Professor at the University of Wisconsin-Madison (UW-Madison) in both the Population Health Sciences and Pathology Departments at the Medical School. She served as director of the Clinical Cytogenetics Laboratory at UW-Madison and the State of Wisconsin Lab of Hygiene for more than 30 years, and has been a faculty member at UW-Madison since 1968.
Dr. Meisner directed the chromosomal studies of the first embryonic stem cell lines, famously derived by Dr. James Thomson in 1998, and has characterized more than 6,000 stem cell samples. In addition to teaching and serving as the Director of the Clinical Cytogenetics Laboratory, Dr. Meisner has extensively researched genetic and cell damage, focusing on the development of various forms of cancer. Dr. Meisner has more than 200 peer-reviewed publications in genetics, cancer and skin disease. Dr. Meisner is board-certified in cytogenetics and a founding member of The American College of Medical Genetics. Dr. Meisner holds a Ph.D. in Genetics from the University of Chicago.
Roberto “Rob” Herrera. M.Sc.
President/Chief Business Officer
Mr. Roberto Herrera has over 20 years of corporate and start-up experience, excelling in the early-stage development of information technology and biotechnology ventures. After starting his career with Bell Laboratories’ Technology Transfer Division, Mr. Herrera held technology management positions at Salomon/Smith Barney and Montgomery Securities, leading to his appointment as Senior Vice President of Bank of America's Global Fixed Income Technology and Operations group. Mr. Herrera later served as consultant for Catapulse, Inc. and VP of Operations for Capstan Systems, Inc.
Mr. Herrera is currently a director of Bioderm, Inc., moderator of the popular Linked-In Stem Cell Research Group and an active member of the Alliance for Regenerative Medicine’s Standards and Technology Committee. Rob holds a M.Sc. in Computer Engineering from the University of Michigan.
Jared Finger, M.Sc
Manager – Characterization Services
Mr. Jared Finger joined Cell Line Genetics Inc. at its inception. He brings over 10 years of management experience and is an expert in mouse cytogenetics. Mr. Finger holds a Master degree in Biotechnology from the University of Wisconsin, Madison.
Mr. Finger serves as a member of the Biotechnology Advisory Board for Madison College and is a part of the Institutional Animal Care and Use Committee for Flugen Inc.
Board of Directors
William “Bill” Checovich, Ph.D
Dr. William Checovich, brings an exceptional level of product development and operational expertise to Cell Line Genetics. Before joining the company as a resident executive, Bill served as Chief Executive Officer for Caden Biosciences, Director of Operations of Drug Discovery Solutions for Invitrogen and Director of Manufacturing / Protein Sciences for Panvera, LLC 3. Dr. Checovich holds a Ph.D. in Biochemistry from the University of Wisconsin - Madison. He is directors at Neurogenomex and is active in mentoring and community service in Madison.
Neal Sandy, M.B.A.
Mr. Neal Sandy brings extensive program management, marketing, product development, international relations and business development experience to the Cell Line Genetics Board. Mr. Sandy has more than 19 years in global business experience in product development, strategic marketing and operations. He is currently Chief Marketing Officer at GE Healthcare's Life Support Solutions and was previously Chief Operating Officer at Cellectar, Inc. Prior to joining GE in 2003, Mr. Sandy spent six years at Datex-Ohmeda and six at Nicolet Biomedical, with primary responsibilities in global new product development, product management and strategic marketing.